Results 11 to 20 of about 465,343 (264)

Eye diseases in travelers

open access: yesInternational Maritime Health, 2020
Travelling has been growing in popularity over the last several decades. Eye diseases, e.g. decreased visual acuity, inflammatory or degenerative lesions, chronic diseases or eye trauma, affect all groups of travelers.
Korzeniewski, Krzysztof; Department of Epidemiology and Tropical Medicine, Military Institute of Medicine, 128 Szaserów St., 04-141 Warsaw, Poland; Polish Society of Maritime, Tropical and Travel Medicine, 9B Powstania Styczniowego St., 81-519 Gdynia, Poland
core   +3 more sources

Diseases of the Eye [PDF]

open access: yesAnnual Review of Medicine, 1952
The purpose of this review of ophthalmic articles appearing in the litera­ ture between September 1950 and September 1951 is to present the salient features of original contributions which either facilitate the understanding of disease processes or bear on medical therapy. Overlapping efforts along similar lines are generally not noted.
I H, LEOPOLD, A H, KEENEY
openaire   +2 more sources

EyeLncDB: A curated database of human long non-coding RNAs related to eye diseases

open access: yes, 2021
Background: Eye diseases (EDs) are disorders of the ocular system, causing visual damage and sightlessness. Different studies have specified a wide range of biological functions of LncRNAs; consequently, their dysfunction directs to several diseases such
Pournoor, Ehsan, Meshkin, Alireza
core   +1 more source

Fibrosis and diseases of the eye [PDF]

open access: yesJournal of Clinical Investigation, 2007
Most diseases that cause catastrophic loss of vision do so as a result of abnormal angiogenesis and wound healing, often in response to tissue ischemia or inflammation. Disruption of the highly ordered tissue architecture in the eye caused by vascular leakage, hemorrhage, and concomitant fibrosis can lead to mechanical disruption of the visual axis and/
openaire   +2 more sources

Diseases of the Eye.

open access: yesThe Journal of Nervous and Mental Disease, 1926
"In this edition the text has again been revised. No great changes have been made, but there have been some additions to the text and illustrations"-Pref. ; "Printed in Great Britain." ; Some plates accompanied by guard sheet with descriptive letterpress. ; Mode of access: Internet.
openaire   +1 more source

The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement

open access: yes, 2021
Rare Eye Diseases (RED) are the leading cause of visual impairment and blindness for children and young adults in Europe. This heterogeneous group of conditions includes over 900 disorders ranging from relatively prevalent disorders such as retinitis ...
Marques JP   +20 more
core   +1 more source

Neutrophils and neutrophil extracellular trap components: emerging biomarkers and therapeutic targets for age-related eye diseases [PDF]

open access: yes, 2021
Age-related eye diseases, including dry eye, glaucoma, age-related macular degeneration, and diabetic retinopathy, represent a major global health issue based on their increasing prevalence and disabling action.
Gasull, Xavier   +7 more
core   +1 more source

Acceptability of Telegenetics for Families with Genetic Eye Diseases

open access: yes, 2021
Healthcare providers around the world have implemented remote routine consultations to minimise disruption during the COVID-19 pandemic. Virtual clinics are particularly suitable for patients with genetic eye diseases as they rely on detailed histories ...
Kirsten Malcolmson   +3 more
core   +1 more source

Precision Medicine through Next-Generation Sequencing in Inherited Eye Diseases in a Korean Cohort

open access: yes, 2021
In this study, we investigated medically or surgically actionable genes in inherited eye disease, based on clinical phenotype and genomic data. This retrospective consecutive case series included 149 patients with inherited eye diseases, seen by a single
Dongheon Surl   +7 more
core   +1 more source

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy